Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Short Report

Lack of cytomegalovirus detection in human glioma

Authors: Araceli Garcia-Martinez, Cristina Alenda, Esperanza Irles, Enrique Ochoa, Teresa Quintanar, Alvaro Rodriguez-Lescure, Jose L. Soto, Victor M. Barbera

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Gliomas are the most common brain tumors and include a variety of histologic types and grades of malignancy. They arise from glial cells and represent approximately 70% of the primary brain tumors. According to the criteria of the World Health Organization (WHO), the majority of gliomas can be classified into four grades of malignancy (I-IV). Virus infection, especially by DNA viruses and retroviruses, which may cause insertion of viral DNA sequences into the host genome, often triggers the host defense mechanisms. Particularly, the DNA methylation machinery can be activated to cause the methylation of foreign movable viral sequences and, therefore, silence viral gene expression. Several studies have shown the presence of Human Cytomegalovirus (HCMV) in glioblastoma, suggesting that the virus may participate in tumor pathogenesis. But this relationship is controversial because many other studies did not detect HCMV in these tumors. This study aims to detect the presence of HCMV in several samples of human glioma (94 formalin-fixed, paraffin-embedded samples and 28 snap-frozen samples) by different sensitive techniques. We have been unable to detect HCMV DNA and proteins in glioma samples. Therefore, arguments used so far to conclude that HCMV is an oncomodulator virus in gliomas must be, in our view, seriously reconsidered.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ohgaki H, Kleihues P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 2009;100(12):2235–41.CrossRefPubMed Ohgaki H, Kleihues P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 2009;100(12):2235–41.CrossRefPubMed
3.
go back to reference Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program. 2011;2011:305–9.PubMed Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program. 2011;2011:305–9.PubMed
4.
go back to reference Mocarski ES Jr, Kemble GW. Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology. 1996;39(5-6):320–30.CrossRefPubMed Mocarski ES Jr, Kemble GW. Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology. 1996;39(5-6):320–30.CrossRefPubMed
5.
go back to reference Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008;325:417–70.PubMed Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008;325:417–70.PubMed
6.
go back to reference Cobbs CS, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62(12):3347–50.PubMed Cobbs CS, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62(12):3347–50.PubMed
9.
go back to reference Solomon IH, et al. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment. J Neuropathol Exp Neurol. 2014;73(11):994–8.CrossRefPubMed Solomon IH, et al. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment. J Neuropathol Exp Neurol. 2014;73(11):994–8.CrossRefPubMed
10.
go back to reference Mitchell DA, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology. 2008;10(1):10–8.CrossRefPubMedPubMedCentral Mitchell DA, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology. 2008;10(1):10–8.CrossRefPubMedPubMedCentral
11.
go back to reference Rahbar A, et al. Low levels of human cytomegalovirus infection in Glioblastoma multiforme associates with patient survival; −a case-control study. Herpesviridae. 2012;3:3.CrossRefPubMedPubMedCentral Rahbar A, et al. Low levels of human cytomegalovirus infection in Glioblastoma multiforme associates with patient survival; −a case-control study. Herpesviridae. 2012;3:3.CrossRefPubMedPubMedCentral
12.
go back to reference Libard S, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One. 2014;9(9):e108861.CrossRefPubMedPubMedCentral Libard S, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One. 2014;9(9):e108861.CrossRefPubMedPubMedCentral
13.
14.
go back to reference Lucas KG, et al. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neuro-Oncol. 2011;103(2):231–8.CrossRef Lucas KG, et al. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neuro-Oncol. 2011;103(2):231–8.CrossRef
15.
go back to reference Fonseca RF, et al. The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz. 2012;107(7):953–4.CrossRefPubMed Fonseca RF, et al. The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz. 2012;107(7):953–4.CrossRefPubMed
16.
go back to reference Ding D, et al. Does the existence of HCMV components predict poor prognosis in glioma? J Neuro-Oncol. 2014;116(3):515–22.CrossRef Ding D, et al. Does the existence of HCMV components predict poor prognosis in glioma? J Neuro-Oncol. 2014;116(3):515–22.CrossRef
17.
go back to reference Lau SK, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol. 2005;18(6):838–43.CrossRefPubMed Lau SK, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol. 2005;18(6):838–43.CrossRefPubMed
18.
go back to reference Poltermann S, et al. Lack of association of herpesviruses with brain tumors. J Neuro-Oncol. 2006;12(2):90–9. Poltermann S, et al. Lack of association of herpesviruses with brain tumors. J Neuro-Oncol. 2006;12(2):90–9.
19.
go back to reference Yamashita Y, et al. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol. 2014;27(7):922–9.CrossRefPubMed Yamashita Y, et al. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol. 2014;27(7):922–9.CrossRefPubMed
20.
go back to reference Baumgarten P, et al. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. Neuro-Oncology. 2014;16(11):1469–77.CrossRefPubMedPubMedCentral Baumgarten P, et al. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. Neuro-Oncology. 2014;16(11):1469–77.CrossRefPubMedPubMedCentral
21.
go back to reference Tang KW, Hellstrand K, Larsson E. Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme. Int J Cancer. 2015;136(4):977–81.CrossRefPubMed Tang KW, Hellstrand K, Larsson E. Absence of cytomegalovirus in high-coverage DNA sequencing of human glioblastoma multiforme. Int J Cancer. 2015;136(4):977–81.CrossRefPubMed
22.
go back to reference Sampson JH, Mitchell DA. Is cytomegalovirus a therapeutic target in glioblastoma? Clin Cancer Res. 2011;17(14):4619–21.CrossRefPubMed Sampson JH, Mitchell DA. Is cytomegalovirus a therapeutic target in glioblastoma? Clin Cancer Res. 2011;17(14):4619–21.CrossRefPubMed
23.
go back to reference Holdhoff M, et al. Absence of cytomegalovirus in Glioblastoma and other high-grade Gliomas by real-time PCR, Immunohistochemistry, and <em>in situ</em> hybridization. Clin Cancer Res. 2017;23(12):3150–7.CrossRefPubMed Holdhoff M, et al. Absence of cytomegalovirus in Glioblastoma and other high-grade Gliomas by real-time PCR, Immunohistochemistry, and <em>in situ</em> hybridization. Clin Cancer Res. 2017;23(12):3150–7.CrossRefPubMed
24.
go back to reference Michaelis M, et al. Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol. 2011;200(1):1–5.CrossRefPubMed Michaelis M, et al. Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol. 2011;200(1):1–5.CrossRefPubMed
25.
go back to reference Cinatl, J., Jr., et al., Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology, 1996. 39(4): p. 259-269. Cinatl, J., Jr., et al., Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology, 1996. 39(4): p. 259-269.
26.
go back to reference Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006;259(3):219–46.CrossRefPubMed Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006;259(3):219–46.CrossRefPubMed
27.
go back to reference Michaelis M, Doerr HW, Cinatl J Jr. Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol. 2009;198(2):79–81.CrossRefPubMed Michaelis M, Doerr HW, Cinatl J Jr. Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol. 2009;198(2):79–81.CrossRefPubMed
29.
go back to reference Lawler SE. Cytomegalovirus and glioblastoma; controversies and opportunities. J Neuro-Oncol. 2015;123(3):465–71.CrossRef Lawler SE. Cytomegalovirus and glioblastoma; controversies and opportunities. J Neuro-Oncol. 2015;123(3):465–71.CrossRef
Metadata
Title
Lack of cytomegalovirus detection in human glioma
Authors
Araceli Garcia-Martinez
Cristina Alenda
Esperanza Irles
Enrique Ochoa
Teresa Quintanar
Alvaro Rodriguez-Lescure
Jose L. Soto
Victor M. Barbera
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0885-3

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue